Comprehensive services to global Pharmaceutical, Biotech & Medical Device companies
Over 450 Bio-analytical methods developed for Indian & global Pharmaceutical majors
Expertise in Clinical Trials & BA / BE to address requirements across therapeutic areas
Lotus Labs has successfully completed 3rd inspection by MHRA, UK
24 USFDA Inspections successfully completed
Beclomethasone mono propionate (BMP) and Beclomethasone Di propionate (BDP) (Simultaneous analysis), Agomelatine, Sacubitril/Valsartan, Sacubitril metabolite (Sacubitrilate),
Valsartan + Hydrochlorothiazide (Simultaneous), Olmesartan + Amlodipine + Hydrochlorothiazide (Simultaneous), Lenalidomide, Loperamide, Estradiol, Lapatinib, Fluticasone (0.5 pg/mL LOQ), Dextromethorphan, Bupropion with three metabolites (Simultaneous), Citric acid in Urine, Fidaxomicin, Cyclosporine, Pimavanserin, Axitinib, Tiotropium (0.1 pg/mL LOQ), Naloxegol, Chlorzoxazone, Remogliflozin + Metabolite, Dothiepin, Vigabadrin, Atazanavir + cobiasostat, Oxybutynin + Pilocarpine, R & S Baclofen, Isoprinosine (P-aminobenzoic acid+Dimethyal-2-propanol inpresence of Isonosine), Tramadol + Celecoxib, Residronate, Free Irinotecan, SN-38 Irinotecan active metabolite, Donepezil+Solifenacin, Amlodipine + Olmesartan+Hydrochlorothiazide, Liposomal encapsulated Irinotecan (LEI), Erythromycin Ethyl Succinat (Total Erythromycin), Diclofenac Gel (1%), Free Erythromycin, Theophylline, Pirfenidone, Sunitinib, Doxepin+metabolite, Fidaxomicin + Metabolite, Amphotericin.